Signature Therapeutics, Inc., is a privately held biopharmaceutical company focused on creating best-in-class medicines that address unmet needs in the area of pain management as well as potentially ADHD. We strive to improve patient care by developing molecules that retain the efficacy of commonly used pain and ADHD agents while reducing or eliminating unwanted side effects and safety concerns. Our proprietary abuse-resistant BIO-MD™ opioid prodrug technology has the potential to meet patients’ needs for effective pain medications while addressing the growing epidemic of prescription opioid drug abuse. Abuse of drugs used to treat ADHD is also a rising concern. We have successfully applied our BIO-MD™ prodrug technology to drugs used to treat these diseases.
